Many of the corporate crises were self-inflicted. As in years past, executives often failed to apply the most basic principles of crisis and reputation management.
The vaccine will be prioritised for the country’s most vulnerable groups. It’s the second Covid vaccine to be cleared for emergency use in the UK after Pfizer and BioNTech.
UK's Medicines and Healthcare products Regulatory Agency tells ThePrint vaccine review includes poring over pages of lab data. If cleared, it will likely boost chances of the vaccine's approval in India.
The proposed cash-and-stock acquisition will add treatments for uncommon blood and immunological disorders to the portfolio of the Cambridge-based drugmaker.
Based on a monkey-adenovirus vector, AstraZeneca’s vaccine reported average effectiveness of 70%. Sputnik is the only Covid vaccine to use two different human-adenovirus vectors.
3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.
Even without a new trial, AstraZeneca can regain confidence in its research and vaccine – which still seems to show great promise – by releasing more granular data.
Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.
MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
COMMENTS